Skip to content

MarketAxess MKTX Treasury Stock Used For Acquisition Of Business

Treasury Stock Used For Acquisition Of Business at other companies

ADMA Biologics logo
ADMA BiologicsADMA
$130.88M
Virtu Financial logo
Virtu FinancialVIRT
$55.79M-37.1%
Constellium logo
ConstelliumCSTM
$28M+86.7%
SPS Commerce logo
SPS CommerceSPSC
$48.64M+21.6%
Cavco Industries logo
Cavco IndustriesCVCO
$30.28M-9.6%
ConocoPhillips logo
ConocoPhillipsCOP
$1.01B-32.9%

Other financials

Income statement

See full
Revenue$233.4M+11.9%
Operating income$100.9M+14.2%
Net income$77.9M+417%
EPS (diluted)$2.20+450%

Balance sheet

See full
Cash & equivalents$548.2M-14.9%
Total debt$292.0M+312%
Total equity$1.2B-11.6%
Total assets$2.3B+22.5%

Cash flow

See full
Operating cash flow-$75.3M-354%
CapEx$259.0K-86.6%
Free cash flow-$75.6M-373%

Valuation

See full
Market cap$4.2B-28.1%

Profitability

See full
Operating margin40.7%-0.6pp
Net margin35.5%+9.0pp
FCF margin31.1%-19.1pp

Returns & leverage

See full
Return on equity24.4%+8.1pp
Debt / equity0.2×+0.2×

Where this comes from

Reported directly by MarketAxess in its filing.

Tagged under the XBRL concept mktx:TreasuryStockUsedForAcquisitionOfBusiness.

The official record: MarketAxess’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about MarketAxess's treasury stock used for acquisition of business.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MarketAxess's treasury stock used for acquisition of business?
MarketAxess (MKTX) reported treasury stock used for acquisition of business of $0 in Q4 2025.
What does treasury stock used for acquisition of business mean?
Indicates the value of treasury shares utilized as consideration for the acquisition of another business or entity. By using existing treasury stock rather than cash, the company manages its capital structure and minimizes dilution for existing shareholders. This metric provides insight into the company's strategy for funding inorganic growth through equity-based transactions.